You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lu AF35700

Showing 1 - 25 of 492
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Parkinson Disease Trial in Toon (Lu AF28996)

Not yet recruiting
  • Parkinson Disease
  • Lu AF28996
  • Toon, Ehime, Japan
    Ehime University Hospital
Aug 16, 2023

Healthy Trial in Leeds (Lu AF35700, Lu AF35700 iv)

Completed
  • Healthy
  • Lu AF35700
  • Lu AF35700 iv
  • Leeds, United Kingdom
    Covance
Oct 31, 2019

Healthy Trial in GZ Groningen (Lu AF90103, Placebo)

Terminated
  • Healthy
  • Lu AF90103
  • Placebo
  • GZ Groningen, Netherlands
    QPS Netherlands B.V.
Dec 16, 2022

Renal Failure Trial in Munich (Lu AF35700)

Terminated
  • Renal Failure
  • Lu AF35700
  • Munich, Germany
    APEX
Sep 26, 2019

Schizophrenia Trial in Worldwide (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Bellflower, California
  • +101 more
Sep 30, 2020

Parkinson Disease Trial in Farmington Hills, Leeuwarden (Lu AF28996)

Recruiting
  • Parkinson Disease
  • Lu AF28996
  • Farmington Hills, Michigan
  • +1 more
Dec 5, 2022

Schizophrenia, Schizoaffective Disorder Trial in Long Beach (Lu AF35700 (10 mg/day), Lu AF35700 (30 mg/day), Quetiapine

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Lu AF35700 (10 mg/day)
  • +2 more
  • Long Beach, California
    US1104
Sep 11, 2019

Cytochrome P450 Interaction Trial in Dallas, Leeds (Lu AF35700, Itraconazole (200 mg), Itraconazole (300 mg))

Completed
  • Cytochrome P450 Interaction
  • Lu AF35700
  • +2 more
  • Dallas, Texas
  • +1 more
Oct 1, 2019

Healthy Participants Trial in London ([11C]-Lu AF88370)

Completed
  • Healthy Participants
  • [11C]-Lu AF88370
  • London, United Kingdom
    Invicro
Jul 12, 2022

Healthy, Alzheimer Trial in United States (Lu AF87908, Placebo)

Recruiting
  • Healthy
  • Alzheimer Disease
  • Lu AF87908
  • Placebo
  • Glendale, California
  • +5 more
Dec 13, 2022

Treatment-resistant Schizophrenia Trial in Worldwide (Lu AF35700, Risperidone, Olanzapine)

Terminated
Has Results
  • Treatment-resistant Schizophrenia
  • Lu AF35700
  • +2 more
  • San Diego, California
  • +40 more
Jan 10, 2020

Multiple System Atrophy Trial in Japan, United States (Lu AF82422, Placebo)

Active, not recruiting
  • Multiple System Atrophy
  • Lu AF82422
  • Placebo
  • Fountain Valley, California
  • +18 more
Dec 5, 2022

Healthy, Parkinson Disease Trial in United States (Lu AF82422, Placebo)

Completed
  • Healthy
  • Parkinson Disease
  • Lu AF82422
  • Placebo
  • Glendale, California
  • +3 more
Oct 5, 2021

Healthy Trial in Groningen (Lu AF88434, Lu AF99722 14C spiked dosage ([14C]-radiolabelled Lu AF88434), Lu AF99723 14C spiked

Completed
  • Healthy
  • Lu AF88434
  • +3 more
  • Groningen, Netherlands
    QPS
Feb 23, 2021

Healthy Trial in Leeds (Lu AF35700 5 mg clinical formulation, Lu AF35700 5 mg commercial formulation, Lu AF35700 10 mg clinical

Completed
  • Healthy
  • Lu AF35700 5 mg clinical formulation
  • +5 more
  • Leeds, United Kingdom
    Covance
Nov 28, 2018

Healthy Trial in Middlesex (Lu AF88434, [11C]-Lu AF88434)

Completed
  • Healthy
  • Lu AF88434
  • [11C]-Lu AF88434
  • Middlesex, United Kingdom
    Parexel International Northwick Park Hospital (Level 7)
Feb 23, 2021

Schizophrenia Trial in Worldwide (Risperidone, Olanzapine, Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Bellflower, California
  • +146 more
Oct 30, 2019

Healthy Trial in Groningen (Lu AF95245, Lu AF95245 14C radiolabelled spiked dosage, Placebo)

Terminated
  • Healthy
  • Lu AF95245
  • +2 more
  • Groningen, Netherlands
    QPS Netherlands BV
May 11, 2020

Healthy Trial in Nottingham (Lu AF11167, [14C]-Lu AF11167, Lu AF11167 MR tablet prototype formulation selected from part A or 1

Completed
  • Healthy
  • Lu AF11167
  • +2 more
  • Nottingham, United Kingdom
    Quotient
Apr 16, 2020

Hepatic Impairment Trial in Munich (Lu AF35700)

Completed
  • Hepatic Impairment
  • Lu AF35700
  • Munich, Germany
    APEX
May 3, 2018

Schizophrenia Trial in Worldwide (Lu AF11167)

Terminated
  • Schizophrenia
  • Lu AF11167
  • Bourgas, Bulgaria
  • +29 more
Sep 21, 2020

Protective Effects of Acupuncture in Cardiac Surgery Trial (acupuncture)

Not yet recruiting
  • Protective Effects of Acupuncture in Cardiac Surgery
  • acupuncture
  • (no location specified)
Nov 2, 2023

Alzheimer Trial in Kuopio, Turku, Stockholm (Lu AF20513, booster vaccine)

Terminated
  • Alzheimer Disease
  • Lu AF20513
  • booster vaccine
  • Kuopio, Finland
  • +2 more
Feb 20, 2020

Alzheimer Trial in Austria, Finland, Sweden (Lu AF20513, low dose, Lu AF20513, medium dose, Lu AF20513, high dose)

Terminated
  • Alzheimer Disease
  • Lu AF20513, low dose
  • +3 more
  • Wien, Austria
  • +4 more
Nov 27, 2019